TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/24 19:16 | 2/2/24 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S.m | -265 | 15.09 | 0 | -18 | -18 | 78 | D | ||||||||||||||
2/1/24 21:47 | 1/30/24 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S.m | -209 | 15.09 | 0 | -14 | -13 | 95 | D | ||||||||||||||
1/26/24 18:04 | 1/24/24 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S.m | -12 | 15.03 | 0 | -1 | -1 | 109 | D | ||||||||||||||
12/28/23 17:47 | 12/26/23 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S.m | -136 | 10.12 | 0 | -13 | -11 | 110 | D | ||||||||||||||
12/22/23 16:21 | 12/20/23 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S | -28 | 10.14 | 0 | -3 | -2 | 123 | D | ||||||||||||||
12/7/23 16:07 | 12/6/23 | NPCE | Neuropace Inc | DE | Health | MdEq | Surgical & Medical Instrument | Morrell Martha | CA | O | Chief Me | S | -90 | 8.16 | 0 | -11 | -8 | 126 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |